Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France
Sponsor: Novartis Pharmaceuticals
Summary
This study is a national, multicenter, prospective, non-interventional study in women with HR+/HER2- locally advanced or metastatic breast cancer (BC), for which a prior clinical decision to initiate ribociclib + endocrine therapy (ET) treatment according to the marketing authorization has been taken and was taken independent and prior to study participation decision.
Official title: Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France: a National, Multicenter, Prospective, Non-interventional Study
Key Details
Gender
FEMALE
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
1019
Start Date
2022-12-13
Completion Date
2028-06-30
Last Updated
2026-03-16
Healthy Volunteers
No
Conditions
Interventions
ribociclib + ET
There is no treatment allocation. Patients administered ribociclib + endocrine Therapy (ET) by prescription will be enrolled.
Locations (82)
Novartis Investigative Site
Nice, Alpes Maritimes, France
Novartis Investigative Site
Marseille, Bouches Du Rhone, France
Novartis Investigative Site
Dijon, Cote D Or, France
Novartis Investigative Site
Saint-Denis, France, France
Novartis Investigative Site
Valenciennes, France, France
Novartis Investigative Site
Saint-Cloud, Hauts De Seine, France
Novartis Investigative Site
Grenoble, Isere, France
Novartis Investigative Site
Reims, Marne, France
Novartis Investigative Site
Toulon, Val De Marne, France
Novartis Investigative Site
Amiens, France
Novartis Investigative Site
Argenteuil, France
Novartis Investigative Site
Avignon, France
Novartis Investigative Site
Bayonne, France
Novartis Investigative Site
Besançon, France
Novartis Investigative Site
Béziers, France
Novartis Investigative Site
Béziers, France
Novartis Investigative Site
Brive-la-Gaillarde, France
Novartis Investigative Site
Cannes, France
Novartis Investigative Site
Carcassonne, France
Novartis Investigative Site
Chalon-sur-Saône, France
Novartis Investigative Site
Chambray-lès-Tours, France
Novartis Investigative Site
Champigny-sur-Marne, France
Novartis Investigative Site
Cherbourg, France
Novartis Investigative Site
Cholet, France
Novartis Investigative Site
Clermont-Ferrand, France
Novartis Investigative Site
Clermont-Ferrand, France
Novartis Investigative Site
Colmar, France
Novartis Investigative Site
Compiègne, France
Novartis Investigative Site
Compiègne, France
Novartis Investigative Site
Corbeil-Essonnes, France
Novartis Investigative Site
Créteil, France
Novartis Investigative Site
Dechy, France
Novartis Investigative Site
Dijon, France
Novartis Investigative Site
Dunkirk, France
Novartis Investigative Site
Eaubonne, France
Novartis Investigative Site
Fréjus, France
Novartis Investigative Site
Gleizé, France
Novartis Investigative Site
La Roche-sur-Yon, France
Novartis Investigative Site
Libourne, France
Novartis Investigative Site
Lyon, France
Novartis Investigative Site
Lyon 08, France
Novartis Investigative Site
Marseille, France
Novartis Investigative Site
Marseille, France
Novartis Investigative Site
Marseille, France
Novartis Investigative Site
Metz, France
Novartis Investigative Site
Metz, France
Novartis Investigative Site
Metz-Tessy, France
Novartis Investigative Site
Montbelliard, France
Novartis Investigative Site
Montpellier, France
Novartis Investigative Site
Nancy, France
Novartis Investigative Site
Neuilly-sur-Seine, France
Novartis Investigative Site
Niort, France
Novartis Investigative Site
Nîmes, France
Novartis Investigative Site
Osny, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Paris, France
Novartis Investigative Site
Perpignan, France
Novartis Investigative Site
Pierre-Bénite, France
Novartis Investigative Site
Poitiers, France
Novartis Investigative Site
Reims, France
Novartis Investigative Site
Rouen, France
Novartis Investigative Site
Rouen, France
Novartis Investigative Site
Saint-Dizier, France
Novartis Investigative Site
Saint-Etienne, France
Novartis Investigative Site
Saint-Etienne, France
Novartis Investigative Site
Saint-Nazaire, France
Novartis Investigative Site
Saint-Pierre, France
Novartis Investigative Site
Saint-Vallier, France
Novartis Investigative Site
Sarcelles, France
Novartis Investigative Site
Soyaux, France
Novartis Investigative Site
St-Malo, France
Novartis Investigative Site
St-Malo, France
Novartis Investigative Site
Suresnes, France
Novartis Investigative Site
Thionville, France
Novartis Investigative Site
Toulon La Seyne, France
Novartis Investigative Site
Toulouse, France
Novartis Investigative Site
Valence, France
Novartis Investigative Site
Vandœuvre-lès-Nancy, France
Novartis Investigative Site
Vantoux, France
Novartis Investigative Site
Villejuif, France
Novartis Investigative Site
Villeurbanne, France